This site makes use of Javascript, please enable your web browser to allow Javascript. Thank you.

Lori Leskin Speaks with The New York Times on New FDA Guidance for Social Media Use b…

June 17, 2014

Lori Leskin Speaks with The New York Times on New FDA Guidance for Social Media Use by Drug Companies

As Seen in The New York Times’ “FDA Proposes Rules for Listing Risks on Social Media”

The New York Times reports that the FDA issued a set of proposed rules on Tuesday that would require pharmaceutical and medical device companies to list the risks of their products in Twitter feeds if benefits are also mentioned. The rules would to other social media platforms that similarly limit message length. The guidelines also allow these industries to fix any information posted by third parties that could be seen as false or misleading.

According to Kaye Scholer Life Sciences Partner Lori Leskin, companies have hesitated to use Facebook and Twitter in the past due to uncertainty in the FDA rules and for fear of censure.

Also of Interest

Professionals

Lori B. Leskin
Partner
icon Email

Legal Services

Offices